nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Oxycodone—Galantamine—Alzheimer's disease	0.283	0.349	CrCrCtD
Nalbuphine—Morphine—Galantamine—Alzheimer's disease	0.264	0.326	CrCrCtD
Nalbuphine—Dihydrocodeine—Galantamine—Alzheimer's disease	0.264	0.326	CrCrCtD
Nalbuphine—OPRM1—telencephalic ventricle—Alzheimer's disease	0.00769	0.233	CbGeAlD
Nalbuphine—Dysphoria—Donepezil—Alzheimer's disease	0.00329	0.0252	CcSEcCtD
Nalbuphine—OPRD1—forebrain—Alzheimer's disease	0.00294	0.0893	CbGeAlD
Nalbuphine—OPRK1—forebrain—Alzheimer's disease	0.00282	0.0856	CbGeAlD
Nalbuphine—OPRD1—telencephalon—Alzheimer's disease	0.00271	0.0821	CbGeAlD
Nalbuphine—Hostility—Donepezil—Alzheimer's disease	0.00257	0.0197	CcSEcCtD
Nalbuphine—Micturition urgency—Donepezil—Alzheimer's disease	0.00251	0.0192	CcSEcCtD
Nalbuphine—Micturition urgency—Rivastigmine—Alzheimer's disease	0.00223	0.0171	CcSEcCtD
Nalbuphine—Delusion—Donepezil—Alzheimer's disease	0.00201	0.0154	CcSEcCtD
Nalbuphine—OPRM1—forebrain—Alzheimer's disease	0.00201	0.0609	CbGeAlD
Nalbuphine—Naloxone—CREB1—Alzheimer's disease	0.00188	0.422	CrCbGaD
Nalbuphine—OPRM1—telencephalon—Alzheimer's disease	0.00185	0.056	CbGeAlD
Nalbuphine—Depersonalisation—Memantine—Alzheimer's disease	0.00184	0.0141	CcSEcCtD
Nalbuphine—Delusion—Memantine—Alzheimer's disease	0.00183	0.014	CcSEcCtD
Nalbuphine—Depersonalisation—Rivastigmine—Alzheimer's disease	0.0018	0.0138	CcSEcCtD
Nalbuphine—Delusion—Rivastigmine—Alzheimer's disease	0.00179	0.0137	CcSEcCtD
Nalbuphine—Numbness—Donepezil—Alzheimer's disease	0.00172	0.0132	CcSEcCtD
Nalbuphine—Sensory loss—Donepezil—Alzheimer's disease	0.00164	0.0126	CcSEcCtD
Nalbuphine—OPRD1—nervous system—Alzheimer's disease	0.0016	0.0485	CbGeAlD
Nalbuphine—Numbness—Memantine—Alzheimer's disease	0.00156	0.0119	CcSEcCtD
Nalbuphine—OPRD1—central nervous system—Alzheimer's disease	0.00154	0.0467	CbGeAlD
Nalbuphine—OPRK1—nervous system—Alzheimer's disease	0.00153	0.0465	CbGeAlD
Nalbuphine—Speech disorder—Memantine—Alzheimer's disease	0.0015	0.0115	CcSEcCtD
Nalbuphine—Sensory loss—Memantine—Alzheimer's disease	0.00149	0.0114	CcSEcCtD
Nalbuphine—OPRK1—central nervous system—Alzheimer's disease	0.00148	0.0447	CbGeAlD
Nalbuphine—Speech disorder—Rivastigmine—Alzheimer's disease	0.00147	0.0113	CcSEcCtD
Nalbuphine—OPRK1—cerebellum—Alzheimer's disease	0.00144	0.0437	CbGeAlD
Nalbuphine—Wheezing—Donepezil—Alzheimer's disease	0.00138	0.0106	CcSEcCtD
Nalbuphine—Euphoric mood—Donepezil—Alzheimer's disease	0.00122	0.00937	CcSEcCtD
Nalbuphine—OPRD1—brain—Alzheimer's disease	0.00122	0.0371	CbGeAlD
Nalbuphine—OPRK1—brain—Alzheimer's disease	0.00117	0.0355	CbGeAlD
Nalbuphine—Pulmonary oedema—Memantine—Alzheimer's disease	0.00115	0.00882	CcSEcCtD
Nalbuphine—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.00113	0.00862	CcSEcCtD
Nalbuphine—OPRM1—nervous system—Alzheimer's disease	0.00109	0.0331	CbGeAlD
Nalbuphine—Pollakiuria—Galantamine—Alzheimer's disease	0.00106	0.00816	CcSEcCtD
Nalbuphine—OPRM1—central nervous system—Alzheimer's disease	0.00105	0.0318	CbGeAlD
Nalbuphine—Depression—Galantamine—Alzheimer's disease	0.00102	0.00785	CcSEcCtD
Nalbuphine—Bradycardia—Galantamine—Alzheimer's disease	0.000939	0.0072	CcSEcCtD
Nalbuphine—Cramp muscle—Donepezil—Alzheimer's disease	0.000931	0.00713	CcSEcCtD
Nalbuphine—Hallucination—Galantamine—Alzheimer's disease	0.000918	0.00703	CcSEcCtD
Nalbuphine—Asthma—Donepezil—Alzheimer's disease	0.000893	0.00684	CcSEcCtD
Nalbuphine—Cardiac arrest—Memantine—Alzheimer's disease	0.000892	0.00684	CcSEcCtD
Nalbuphine—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.000873	0.00669	CcSEcCtD
Nalbuphine—Sweating increased—Donepezil—Alzheimer's disease	0.00087	0.00667	CcSEcCtD
Nalbuphine—Flushing—Galantamine—Alzheimer's disease	0.000856	0.00656	CcSEcCtD
Nalbuphine—OPRM1—brain—Alzheimer's disease	0.000833	0.0253	CbGeAlD
Nalbuphine—Cramp muscle—Rivastigmine—Alzheimer's disease	0.000827	0.00633	CcSEcCtD
Nalbuphine—Pollakiuria—Donepezil—Alzheimer's disease	0.000825	0.00632	CcSEcCtD
Nalbuphine—Asthma—Memantine—Alzheimer's disease	0.000811	0.00621	CcSEcCtD
Nalbuphine—Bronchospasm—Memantine—Alzheimer's disease	0.000798	0.00611	CcSEcCtD
Nalbuphine—Depression—Donepezil—Alzheimer's disease	0.000794	0.00608	CcSEcCtD
Nalbuphine—Sweating increased—Memantine—Alzheimer's disease	0.00079	0.00605	CcSEcCtD
Nalbuphine—Tension—Galantamine—Alzheimer's disease	0.000788	0.00604	CcSEcCtD
Nalbuphine—Dysgeusia—Galantamine—Alzheimer's disease	0.000786	0.00603	CcSEcCtD
Nalbuphine—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00078	0.00598	CcSEcCtD
Nalbuphine—Nervousness—Galantamine—Alzheimer's disease	0.00078	0.00598	CcSEcCtD
Nalbuphine—Sweating increased—Rivastigmine—Alzheimer's disease	0.000773	0.00592	CcSEcCtD
Nalbuphine—Muscle spasms—Galantamine—Alzheimer's disease	0.000772	0.00592	CcSEcCtD
Nalbuphine—Vision blurred—Galantamine—Alzheimer's disease	0.000757	0.0058	CcSEcCtD
Nalbuphine—Tremor—Galantamine—Alzheimer's disease	0.000752	0.00576	CcSEcCtD
Nalbuphine—Pollakiuria—Memantine—Alzheimer's disease	0.000749	0.00574	CcSEcCtD
Nalbuphine—Agitation—Galantamine—Alzheimer's disease	0.000738	0.00565	CcSEcCtD
Nalbuphine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000733	0.00562	CcSEcCtD
Nalbuphine—Bradycardia—Donepezil—Alzheimer's disease	0.000728	0.00558	CcSEcCtD
Nalbuphine—Vertigo—Galantamine—Alzheimer's disease	0.000722	0.00553	CcSEcCtD
Nalbuphine—Depression—Memantine—Alzheimer's disease	0.000721	0.00552	CcSEcCtD
Nalbuphine—Syncope—Galantamine—Alzheimer's disease	0.00072	0.00552	CcSEcCtD
Nalbuphine—Hallucination—Donepezil—Alzheimer's disease	0.000711	0.00545	CcSEcCtD
Nalbuphine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000711	0.00545	CcSEcCtD
Nalbuphine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000706	0.00541	CcSEcCtD
Nalbuphine—Depression—Rivastigmine—Alzheimer's disease	0.000705	0.0054	CcSEcCtD
Nalbuphine—Convulsion—Galantamine—Alzheimer's disease	0.000696	0.00533	CcSEcCtD
Nalbuphine—Hypertension—Galantamine—Alzheimer's disease	0.000693	0.00531	CcSEcCtD
Nalbuphine—Anxiety—Galantamine—Alzheimer's disease	0.000681	0.00522	CcSEcCtD
Nalbuphine—Dry mouth—Galantamine—Alzheimer's disease	0.000669	0.00512	CcSEcCtD
Nalbuphine—Confusional state—Galantamine—Alzheimer's disease	0.000661	0.00506	CcSEcCtD
Nalbuphine—Bradycardia—Memantine—Alzheimer's disease	0.000661	0.00506	CcSEcCtD
Nalbuphine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000647	0.00495	CcSEcCtD
Nalbuphine—Hallucination—Memantine—Alzheimer's disease	0.000646	0.00495	CcSEcCtD
Nalbuphine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000646	0.00495	CcSEcCtD
Nalbuphine—Shock—Galantamine—Alzheimer's disease	0.000645	0.00494	CcSEcCtD
Nalbuphine—Tachycardia—Galantamine—Alzheimer's disease	0.00064	0.0049	CcSEcCtD
Nalbuphine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000634	0.00485	CcSEcCtD
Nalbuphine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000632	0.00484	CcSEcCtD
Nalbuphine—Hallucination—Rivastigmine—Alzheimer's disease	0.000632	0.00484	CcSEcCtD
Nalbuphine—Erythema—Donepezil—Alzheimer's disease	0.000622	0.00477	CcSEcCtD
Nalbuphine—Hypotension—Galantamine—Alzheimer's disease	0.000612	0.00469	CcSEcCtD
Nalbuphine—Tension—Donepezil—Alzheimer's disease	0.000611	0.00468	CcSEcCtD
Nalbuphine—Dysgeusia—Donepezil—Alzheimer's disease	0.000609	0.00467	CcSEcCtD
Nalbuphine—Nervousness—Donepezil—Alzheimer's disease	0.000604	0.00463	CcSEcCtD
Nalbuphine—Flushing—Memantine—Alzheimer's disease	0.000602	0.00462	CcSEcCtD
Nalbuphine—Muscle spasms—Donepezil—Alzheimer's disease	0.000598	0.00458	CcSEcCtD
Nalbuphine—Flushing—Rivastigmine—Alzheimer's disease	0.000589	0.00452	CcSEcCtD
Nalbuphine—Paraesthesia—Galantamine—Alzheimer's disease	0.000589	0.00451	CcSEcCtD
Nalbuphine—Vision blurred—Donepezil—Alzheimer's disease	0.000587	0.00449	CcSEcCtD
Nalbuphine—Tremor—Donepezil—Alzheimer's disease	0.000583	0.00447	CcSEcCtD
Nalbuphine—Somnolence—Galantamine—Alzheimer's disease	0.000583	0.00446	CcSEcCtD
Nalbuphine—Dyspepsia—Galantamine—Alzheimer's disease	0.000577	0.00442	CcSEcCtD
Nalbuphine—Agitation—Donepezil—Alzheimer's disease	0.000572	0.00438	CcSEcCtD
Nalbuphine—Vertigo—Donepezil—Alzheimer's disease	0.000559	0.00428	CcSEcCtD
Nalbuphine—Syncope—Donepezil—Alzheimer's disease	0.000558	0.00428	CcSEcCtD
Nalbuphine—Tension—Memantine—Alzheimer's disease	0.000555	0.00425	CcSEcCtD
Nalbuphine—Dysgeusia—Memantine—Alzheimer's disease	0.000553	0.00424	CcSEcCtD
Nalbuphine—Erythema—Rivastigmine—Alzheimer's disease	0.000553	0.00424	CcSEcCtD
Nalbuphine—Nervousness—Memantine—Alzheimer's disease	0.000549	0.0042	CcSEcCtD
Nalbuphine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000547	0.00419	CcSEcCtD
Nalbuphine—Tension—Rivastigmine—Alzheimer's disease	0.000543	0.00416	CcSEcCtD
Nalbuphine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000541	0.00415	CcSEcCtD
Nalbuphine—Feeling abnormal—Galantamine—Alzheimer's disease	0.00054	0.00414	CcSEcCtD
Nalbuphine—Convulsion—Donepezil—Alzheimer's disease	0.000539	0.00413	CcSEcCtD
Nalbuphine—Hypertension—Donepezil—Alzheimer's disease	0.000537	0.00412	CcSEcCtD
Nalbuphine—Nervousness—Rivastigmine—Alzheimer's disease	0.000537	0.00411	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000536	0.00411	CcSEcCtD
Nalbuphine—Vision blurred—Memantine—Alzheimer's disease	0.000533	0.00408	CcSEcCtD
Nalbuphine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000532	0.00407	CcSEcCtD
Nalbuphine—Tremor—Memantine—Alzheimer's disease	0.000529	0.00406	CcSEcCtD
Nalbuphine—Anxiety—Donepezil—Alzheimer's disease	0.000528	0.00405	CcSEcCtD
Nalbuphine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000521	0.00399	CcSEcCtD
Nalbuphine—Agitation—Memantine—Alzheimer's disease	0.000519	0.00398	CcSEcCtD
Nalbuphine—Dry mouth—Donepezil—Alzheimer's disease	0.000518	0.00397	CcSEcCtD
Nalbuphine—Abdominal pain—Galantamine—Alzheimer's disease	0.000518	0.00397	CcSEcCtD
Nalbuphine—Body temperature increased—Galantamine—Alzheimer's disease	0.000518	0.00397	CcSEcCtD
Nalbuphine—Tremor—Rivastigmine—Alzheimer's disease	0.000518	0.00397	CcSEcCtD
Nalbuphine—Confusional state—Donepezil—Alzheimer's disease	0.000512	0.00392	CcSEcCtD
Nalbuphine—Agitation—Rivastigmine—Alzheimer's disease	0.000508	0.00389	CcSEcCtD
Nalbuphine—Oedema—Donepezil—Alzheimer's disease	0.000508	0.00389	CcSEcCtD
Nalbuphine—Vertigo—Memantine—Alzheimer's disease	0.000508	0.00389	CcSEcCtD
Nalbuphine—Syncope—Memantine—Alzheimer's disease	0.000507	0.00388	CcSEcCtD
Nalbuphine—Shock—Donepezil—Alzheimer's disease	0.0005	0.00383	CcSEcCtD
Nalbuphine—Vertigo—Rivastigmine—Alzheimer's disease	0.000497	0.00381	CcSEcCtD
Nalbuphine—Loss of consciousness—Memantine—Alzheimer's disease	0.000497	0.00381	CcSEcCtD
Nalbuphine—Syncope—Rivastigmine—Alzheimer's disease	0.000496	0.0038	CcSEcCtD
Nalbuphine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000491	0.00376	CcSEcCtD
Nalbuphine—Convulsion—Memantine—Alzheimer's disease	0.00049	0.00375	CcSEcCtD
Nalbuphine—Hypertension—Memantine—Alzheimer's disease	0.000488	0.00374	CcSEcCtD
Nalbuphine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000486	0.00372	CcSEcCtD
Nalbuphine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000483	0.0037	CcSEcCtD
Nalbuphine—Anxiety—Memantine—Alzheimer's disease	0.000479	0.00367	CcSEcCtD
Nalbuphine—Convulsion—Rivastigmine—Alzheimer's disease	0.000479	0.00367	CcSEcCtD
Nalbuphine—Hypertension—Rivastigmine—Alzheimer's disease	0.000477	0.00366	CcSEcCtD
Nalbuphine—Hypotension—Donepezil—Alzheimer's disease	0.000475	0.00364	CcSEcCtD
Nalbuphine—Dry mouth—Memantine—Alzheimer's disease	0.000471	0.0036	CcSEcCtD
Nalbuphine—Asthenia—Galantamine—Alzheimer's disease	0.00047	0.0036	CcSEcCtD
Nalbuphine—Anxiety—Rivastigmine—Alzheimer's disease	0.000469	0.00359	CcSEcCtD
Nalbuphine—Confusional state—Memantine—Alzheimer's disease	0.000465	0.00356	CcSEcCtD
Nalbuphine—Oedema—Memantine—Alzheimer's disease	0.000461	0.00353	CcSEcCtD
Nalbuphine—Dry mouth—Rivastigmine—Alzheimer's disease	0.00046	0.00353	CcSEcCtD
Nalbuphine—Paraesthesia—Donepezil—Alzheimer's disease	0.000456	0.00349	CcSEcCtD
Nalbuphine—Confusional state—Rivastigmine—Alzheimer's disease	0.000455	0.00349	CcSEcCtD
Nalbuphine—Shock—Memantine—Alzheimer's disease	0.000454	0.00348	CcSEcCtD
Nalbuphine—Dyspnoea—Donepezil—Alzheimer's disease	0.000453	0.00347	CcSEcCtD
Nalbuphine—Somnolence—Donepezil—Alzheimer's disease	0.000452	0.00346	CcSEcCtD
Nalbuphine—Oedema—Rivastigmine—Alzheimer's disease	0.000451	0.00346	CcSEcCtD
Nalbuphine—Tachycardia—Memantine—Alzheimer's disease	0.00045	0.00345	CcSEcCtD
Nalbuphine—Dyspepsia—Donepezil—Alzheimer's disease	0.000447	0.00343	CcSEcCtD
Nalbuphine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000446	0.00342	CcSEcCtD
Nalbuphine—Shock—Rivastigmine—Alzheimer's disease	0.000444	0.0034	CcSEcCtD
Nalbuphine—Tachycardia—Rivastigmine—Alzheimer's disease	0.00044	0.00337	CcSEcCtD
Nalbuphine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000436	0.00334	CcSEcCtD
Nalbuphine—Dizziness—Galantamine—Alzheimer's disease	0.000433	0.00332	CcSEcCtD
Nalbuphine—Hypotension—Memantine—Alzheimer's disease	0.000431	0.0033	CcSEcCtD
Nalbuphine—Hypotension—Rivastigmine—Alzheimer's disease	0.000422	0.00323	CcSEcCtD
Nalbuphine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000419	0.00321	CcSEcCtD
Nalbuphine—Vomiting—Galantamine—Alzheimer's disease	0.000417	0.00319	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000415	0.00318	CcSEcCtD
Nalbuphine—Paraesthesia—Memantine—Alzheimer's disease	0.000414	0.00317	CcSEcCtD
Nalbuphine—Rash—Galantamine—Alzheimer's disease	0.000413	0.00317	CcSEcCtD
Nalbuphine—Dermatitis—Galantamine—Alzheimer's disease	0.000413	0.00316	CcSEcCtD
Nalbuphine—Dyspnoea—Memantine—Alzheimer's disease	0.000411	0.00315	CcSEcCtD
Nalbuphine—Headache—Galantamine—Alzheimer's disease	0.000411	0.00315	CcSEcCtD
Nalbuphine—Somnolence—Memantine—Alzheimer's disease	0.00041	0.00314	CcSEcCtD
Nalbuphine—Dyspepsia—Memantine—Alzheimer's disease	0.000406	0.00311	CcSEcCtD
Nalbuphine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000405	0.0031	CcSEcCtD
Nalbuphine—Urticaria—Donepezil—Alzheimer's disease	0.000404	0.00309	CcSEcCtD
Nalbuphine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000402	0.00308	CcSEcCtD
Nalbuphine—Body temperature increased—Donepezil—Alzheimer's disease	0.000402	0.00308	CcSEcCtD
Nalbuphine—Abdominal pain—Donepezil—Alzheimer's disease	0.000402	0.00308	CcSEcCtD
Nalbuphine—Somnolence—Rivastigmine—Alzheimer's disease	0.000401	0.00307	CcSEcCtD
Nalbuphine—Methylnaltrexone—CYP2D6—Alzheimer's disease	0.000399	0.0897	CrCbGaD
Nalbuphine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000397	0.00304	CcSEcCtD
Nalbuphine—Nausea—Galantamine—Alzheimer's disease	0.000389	0.00298	CcSEcCtD
Nalbuphine—Feeling abnormal—Memantine—Alzheimer's disease	0.00038	0.00291	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000377	0.00289	CcSEcCtD
Nalbuphine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000374	0.00287	CcSEcCtD
Nalbuphine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000372	0.00285	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000369	0.00283	CcSEcCtD
Nalbuphine—Urticaria—Memantine—Alzheimer's disease	0.000366	0.00281	CcSEcCtD
Nalbuphine—Naloxone—ESR1—Alzheimer's disease	0.000365	0.082	CrCbGaD
Nalbuphine—Body temperature increased—Memantine—Alzheimer's disease	0.000365	0.00279	CcSEcCtD
Nalbuphine—Abdominal pain—Memantine—Alzheimer's disease	0.000365	0.00279	CcSEcCtD
Nalbuphine—Asthenia—Donepezil—Alzheimer's disease	0.000364	0.00279	CcSEcCtD
Nalbuphine—Pruritus—Donepezil—Alzheimer's disease	0.000359	0.00275	CcSEcCtD
Nalbuphine—Urticaria—Rivastigmine—Alzheimer's disease	0.000358	0.00275	CcSEcCtD
Nalbuphine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000357	0.00273	CcSEcCtD
Nalbuphine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000357	0.00273	CcSEcCtD
Nalbuphine—Hypersensitivity—Memantine—Alzheimer's disease	0.00034	0.0026	CcSEcCtD
Nalbuphine—Dihydrocodeine—CYP2D6—Alzheimer's disease	0.00034	0.0763	CrCbGaD
Nalbuphine—Dizziness—Donepezil—Alzheimer's disease	0.000336	0.00257	CcSEcCtD
Nalbuphine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000332	0.00255	CcSEcCtD
Nalbuphine—Asthenia—Memantine—Alzheimer's disease	0.000331	0.00254	CcSEcCtD
Nalbuphine—Pruritus—Memantine—Alzheimer's disease	0.000326	0.0025	CcSEcCtD
Nalbuphine—Asthenia—Rivastigmine—Alzheimer's disease	0.000324	0.00248	CcSEcCtD
Nalbuphine—Vomiting—Donepezil—Alzheimer's disease	0.000323	0.00247	CcSEcCtD
Nalbuphine—Rash—Donepezil—Alzheimer's disease	0.00032	0.00245	CcSEcCtD
Nalbuphine—Dermatitis—Donepezil—Alzheimer's disease	0.00032	0.00245	CcSEcCtD
Nalbuphine—Pruritus—Rivastigmine—Alzheimer's disease	0.000319	0.00245	CcSEcCtD
Nalbuphine—Headache—Donepezil—Alzheimer's disease	0.000318	0.00244	CcSEcCtD
Nalbuphine—Hydromorphone—PTGS1—Alzheimer's disease	0.000317	0.0712	CrCbGaD
Nalbuphine—Dizziness—Memantine—Alzheimer's disease	0.000305	0.00234	CcSEcCtD
Nalbuphine—Nausea—Donepezil—Alzheimer's disease	0.000302	0.00231	CcSEcCtD
Nalbuphine—Dizziness—Rivastigmine—Alzheimer's disease	0.000298	0.00229	CcSEcCtD
Nalbuphine—Oxymorphone—CYP2D6—Alzheimer's disease	0.000298	0.0669	CrCbGaD
Nalbuphine—Vomiting—Memantine—Alzheimer's disease	0.000293	0.00225	CcSEcCtD
Nalbuphine—Rash—Memantine—Alzheimer's disease	0.000291	0.00223	CcSEcCtD
Nalbuphine—Dermatitis—Memantine—Alzheimer's disease	0.000291	0.00223	CcSEcCtD
Nalbuphine—Headache—Memantine—Alzheimer's disease	0.000289	0.00221	CcSEcCtD
Nalbuphine—Vomiting—Rivastigmine—Alzheimer's disease	0.000287	0.0022	CcSEcCtD
Nalbuphine—Rash—Rivastigmine—Alzheimer's disease	0.000284	0.00218	CcSEcCtD
Nalbuphine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000284	0.00218	CcSEcCtD
Nalbuphine—Headache—Rivastigmine—Alzheimer's disease	0.000283	0.00217	CcSEcCtD
Nalbuphine—Nausea—Memantine—Alzheimer's disease	0.000274	0.0021	CcSEcCtD
Nalbuphine—Nausea—Rivastigmine—Alzheimer's disease	0.000268	0.00205	CcSEcCtD
Nalbuphine—Oxycodone—CYP2D6—Alzheimer's disease	0.000238	0.0533	CrCbGaD
Nalbuphine—Buprenorphine—CYP2D6—Alzheimer's disease	0.000219	0.0492	CrCbGaD
Nalbuphine—Hydromorphone—CYP2D6—Alzheimer's disease	0.000216	0.0484	CrCbGaD
Nalbuphine—Morphine—CYP2D6—Alzheimer's disease	0.000183	0.0412	CrCbGaD
Nalbuphine—OPRM1—Signaling Pathways—TTR—Alzheimer's disease	3.6e-05	0.00167	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	3.58e-05	0.00166	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—NPS—Alzheimer's disease	3.58e-05	0.00166	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PPP3CA—Alzheimer's disease	3.56e-05	0.00165	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HTR6—Alzheimer's disease	3.55e-05	0.00164	CbGpPWpGaD
Nalbuphine—OPRM1—TCR Signaling Pathway—AKT1—Alzheimer's disease	3.55e-05	0.00164	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PLCB1—Alzheimer's disease	3.46e-05	0.0016	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—NPS—Alzheimer's disease	3.46e-05	0.0016	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—NPY—Alzheimer's disease	3.43e-05	0.00159	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—GAB2—Alzheimer's disease	3.42e-05	0.00158	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—SST—Alzheimer's disease	3.42e-05	0.00158	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IAPP—Alzheimer's disease	3.41e-05	0.00158	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—APP—Alzheimer's disease	3.33e-05	0.00154	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CRH—Alzheimer's disease	3.31e-05	0.00153	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—GAB2—Alzheimer's disease	3.3e-05	0.00153	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—SST—Alzheimer's disease	3.3e-05	0.00153	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CCL2—Alzheimer's disease	3.28e-05	0.00152	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDK5—Alzheimer's disease	3.23e-05	0.0015	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—F2—Alzheimer's disease	3.23e-05	0.00149	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PSENEN—Alzheimer's disease	3.22e-05	0.00149	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—APP—Alzheimer's disease	3.22e-05	0.00149	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—NPY—Alzheimer's disease	3.2e-05	0.00148	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	3.19e-05	0.00148	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CCR5—Alzheimer's disease	3.18e-05	0.00147	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—IAPP—Alzheimer's disease	3.18e-05	0.00147	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APH1A—Alzheimer's disease	3.18e-05	0.00147	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PYY—Alzheimer's disease	3.15e-05	0.00146	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PLCB1—Alzheimer's disease	3.14e-05	0.00145	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—NPS—Alzheimer's disease	3.14e-05	0.00145	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PPP3CA—Alzheimer's disease	3.13e-05	0.00145	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—HTR2A—Alzheimer's disease	3.11e-05	0.00144	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HTR6—Alzheimer's disease	3.11e-05	0.00144	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NCSTN—Alzheimer's disease	3.09e-05	0.00143	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CRH—Alzheimer's disease	3.08e-05	0.00143	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PLCB1—Alzheimer's disease	3.03e-05	0.0014	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LRP1—Alzheimer's disease	3.02e-05	0.0014	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—GAB2—Alzheimer's disease	3e-05	0.00139	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—SST—Alzheimer's disease	3e-05	0.00139	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GAL—Alzheimer's disease	2.95e-05	0.00136	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GFAP—Alzheimer's disease	2.95e-05	0.00136	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—NPS—Alzheimer's disease	2.92e-05	0.00135	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—APP—Alzheimer's disease	2.92e-05	0.00135	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—NPY—Alzheimer's disease	2.9e-05	0.00134	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IAPP—Alzheimer's disease	2.88e-05	0.00134	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CCL2—Alzheimer's disease	2.88e-05	0.00133	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PSENEN—Alzheimer's disease	2.82e-05	0.00131	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CRH—Alzheimer's disease	2.8e-05	0.0013	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—SST—Alzheimer's disease	2.79e-05	0.00129	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—GAB2—Alzheimer's disease	2.79e-05	0.00129	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APH1A—Alzheimer's disease	2.78e-05	0.00129	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PLCB1—Alzheimer's disease	2.76e-05	0.00128	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDK5—Alzheimer's disease	2.73e-05	0.00126	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—F2—Alzheimer's disease	2.73e-05	0.00126	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—APP—Alzheimer's disease	2.72e-05	0.00126	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NCSTN—Alzheimer's disease	2.71e-05	0.00126	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—NPS—Alzheimer's disease	2.65e-05	0.00123	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LRP1—Alzheimer's disease	2.64e-05	0.00122	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PPP3CA—Alzheimer's disease	2.64e-05	0.00122	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HTR6—Alzheimer's disease	2.63e-05	0.00122	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—A2M—Alzheimer's disease	2.6e-05	0.0012	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GAL—Alzheimer's disease	2.58e-05	0.0012	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GFAP—Alzheimer's disease	2.58e-05	0.0012	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PLCB1—Alzheimer's disease	2.56e-05	0.00119	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PRKCG—Alzheimer's disease	2.56e-05	0.00118	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—GAB2—Alzheimer's disease	2.53e-05	0.00117	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—SST—Alzheimer's disease	2.53e-05	0.00117	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PSEN2—Alzheimer's disease	2.51e-05	0.00116	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—APP—Alzheimer's disease	2.47e-05	0.00114	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CCL2—Alzheimer's disease	2.43e-05	0.00113	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CCR5—Alzheimer's disease	2.42e-05	0.00112	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PSENEN—Alzheimer's disease	2.39e-05	0.0011	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.37e-05	0.0011	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APH1A—Alzheimer's disease	2.35e-05	0.00109	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PLCB1—Alzheimer's disease	2.33e-05	0.00108	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PRKCG—Alzheimer's disease	2.32e-05	0.00108	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NPY—Alzheimer's disease	2.31e-05	0.00107	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IAPP—Alzheimer's disease	2.3e-05	0.00106	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NCSTN—Alzheimer's disease	2.29e-05	0.00106	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—A2M—Alzheimer's disease	2.28e-05	0.00105	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PRKCG—Alzheimer's disease	2.24e-05	0.00104	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LRP1—Alzheimer's disease	2.23e-05	0.00103	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CRH—Alzheimer's disease	2.23e-05	0.00103	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PSEN2—Alzheimer's disease	2.2e-05	0.00102	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCR5—Alzheimer's disease	2.2e-05	0.00102	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GFAP—Alzheimer's disease	2.18e-05	0.00101	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GAL—Alzheimer's disease	2.18e-05	0.00101	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—HTR2A—Alzheimer's disease	2.15e-05	0.000998	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CCR5—Alzheimer's disease	2.13e-05	0.000984	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NPS—Alzheimer's disease	2.12e-05	0.00098	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PPP3CA—Alzheimer's disease	2.11e-05	0.000975	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—HTR2A—Alzheimer's disease	2.08e-05	0.000963	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—F2—Alzheimer's disease	2.08e-05	0.000963	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTK2B—Alzheimer's disease	2.07e-05	0.000961	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PRKCG—Alzheimer's disease	2.04e-05	0.000943	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NPY—Alzheimer's disease	2.03e-05	0.000939	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GAB2—Alzheimer's disease	2.02e-05	0.000935	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NTRK2—Alzheimer's disease	2.02e-05	0.000935	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SST—Alzheimer's disease	2.02e-05	0.000935	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IAPP—Alzheimer's disease	2.02e-05	0.000933	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CALM1—Alzheimer's disease	2.01e-05	0.000931	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GSK3A—Alzheimer's disease	2e-05	0.000926	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APP—Alzheimer's disease	1.97e-05	0.000911	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CRH—Alzheimer's disease	1.96e-05	0.000906	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCR5—Alzheimer's disease	1.93e-05	0.000894	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—A2M—Alzheimer's disease	1.92e-05	0.000891	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.9e-05	0.000878	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.89e-05	0.000875	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—F2—Alzheimer's disease	1.89e-05	0.000875	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PSEN2—Alzheimer's disease	1.86e-05	0.000863	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PLCB1—Alzheimer's disease	1.86e-05	0.000859	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NPS—Alzheimer's disease	1.86e-05	0.000859	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.85e-05	0.000855	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—F2—Alzheimer's disease	1.82e-05	0.000845	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTK2B—Alzheimer's disease	1.82e-05	0.000842	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.8e-05	0.000832	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SST—Alzheimer's disease	1.77e-05	0.000819	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GAB2—Alzheimer's disease	1.77e-05	0.000819	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NTRK2—Alzheimer's disease	1.77e-05	0.000819	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CALM1—Alzheimer's disease	1.76e-05	0.000816	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.76e-05	0.000814	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GSK3A—Alzheimer's disease	1.75e-05	0.000812	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NGFR—Alzheimer's disease	1.73e-05	0.000802	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APP—Alzheimer's disease	1.72e-05	0.000799	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.72e-05	0.000797	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CREB1—Alzheimer's disease	1.72e-05	0.000797	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NPY—Alzheimer's disease	1.71e-05	0.000794	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IAPP—Alzheimer's disease	1.7e-05	0.000789	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADAM10—Alzheimer's disease	1.69e-05	0.000783	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCL2—Alzheimer's disease	1.68e-05	0.00078	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—F2—Alzheimer's disease	1.66e-05	0.000767	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CRH—Alzheimer's disease	1.65e-05	0.000766	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCR5—Alzheimer's disease	1.63e-05	0.000755	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PLCB1—Alzheimer's disease	1.63e-05	0.000754	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—S100B—Alzheimer's disease	1.6e-05	0.000741	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.6e-05	0.000739	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NPS—Alzheimer's disease	1.57e-05	0.000726	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.56e-05	0.000722	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—F2—Alzheimer's disease	1.54e-05	0.000714	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTK2B—Alzheimer's disease	1.54e-05	0.000712	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF2—Alzheimer's disease	1.52e-05	0.000705	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NGFR—Alzheimer's disease	1.52e-05	0.000703	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CREB1—Alzheimer's disease	1.51e-05	0.000699	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GAB2—Alzheimer's disease	1.5e-05	0.000693	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NTRK2—Alzheimer's disease	1.5e-05	0.000693	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SST—Alzheimer's disease	1.5e-05	0.000693	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CALM1—Alzheimer's disease	1.49e-05	0.00069	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADAM10—Alzheimer's disease	1.48e-05	0.000687	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GSK3A—Alzheimer's disease	1.48e-05	0.000687	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCL2—Alzheimer's disease	1.48e-05	0.000684	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF1R—Alzheimer's disease	1.47e-05	0.000682	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APP—Alzheimer's disease	1.46e-05	0.000675	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LPL—Alzheimer's disease	1.41e-05	0.000654	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—S100B—Alzheimer's disease	1.4e-05	0.000649	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—F2—Alzheimer's disease	1.4e-05	0.000648	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MEF2C—Alzheimer's disease	1.4e-05	0.000648	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PLCB1—Alzheimer's disease	1.38e-05	0.000637	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PRKCG—Alzheimer's disease	1.37e-05	0.000636	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NGF—Alzheimer's disease	1.34e-05	0.000619	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF2—Alzheimer's disease	1.34e-05	0.000618	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCR5—Alzheimer's disease	1.3e-05	0.000602	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF1R—Alzheimer's disease	1.29e-05	0.000598	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NGFR—Alzheimer's disease	1.28e-05	0.000594	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CREB1—Alzheimer's disease	1.28e-05	0.00059	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HTR2A—Alzheimer's disease	1.27e-05	0.000589	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADAM10—Alzheimer's disease	1.25e-05	0.00058	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCL2—Alzheimer's disease	1.25e-05	0.000578	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LPL—Alzheimer's disease	1.24e-05	0.000573	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MEF2C—Alzheimer's disease	1.23e-05	0.000568	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PRKCG—Alzheimer's disease	1.2e-05	0.000557	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CALM1—Alzheimer's disease	1.19e-05	0.00055	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—S100B—Alzheimer's disease	1.19e-05	0.000549	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LEP—Alzheimer's disease	1.18e-05	0.000548	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOE—Alzheimer's disease	1.18e-05	0.000548	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CAV1—Alzheimer's disease	1.17e-05	0.000543	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NGF—Alzheimer's disease	1.17e-05	0.000543	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCR5—Alzheimer's disease	1.14e-05	0.000528	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ESR1—Alzheimer's disease	1.13e-05	0.000523	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF2—Alzheimer's disease	1.13e-05	0.000523	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HTR2A—Alzheimer's disease	1.12e-05	0.000517	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—F2—Alzheimer's disease	1.12e-05	0.000517	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.09e-05	0.000506	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF1R—Alzheimer's disease	1.09e-05	0.000505	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LPL—Alzheimer's disease	1.05e-05	0.000484	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CALM1—Alzheimer's disease	1.04e-05	0.000482	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LEP—Alzheimer's disease	1.04e-05	0.00048	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOE—Alzheimer's disease	1.04e-05	0.00048	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MEF2C—Alzheimer's disease	1.04e-05	0.00048	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CAV1—Alzheimer's disease	1.03e-05	0.000476	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GSK3B—Alzheimer's disease	1.02e-05	0.000474	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRKCG—Alzheimer's disease	1.02e-05	0.000471	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CREB1—Alzheimer's disease	1.02e-05	0.000471	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—INS—Alzheimer's disease	1.01e-05	0.000468	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL2—Alzheimer's disease	9.95e-06	0.000461	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NGF—Alzheimer's disease	9.91e-06	0.000459	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ESR1—Alzheimer's disease	9.91e-06	0.000459	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—F2—Alzheimer's disease	9.79e-06	0.000453	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF1—Alzheimer's disease	9.78e-06	0.000453	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCR5—Alzheimer's disease	9.64e-06	0.000446	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOTCH1—Alzheimer's disease	9.58e-06	0.000443	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HTR2A—Alzheimer's disease	9.43e-06	0.000437	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GSK3B—Alzheimer's disease	8.99e-06	0.000416	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CREB1—Alzheimer's disease	8.91e-06	0.000413	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOS3—Alzheimer's disease	8.87e-06	0.00041	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—INS—Alzheimer's disease	8.86e-06	0.00041	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CALM1—Alzheimer's disease	8.8e-06	0.000407	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LEP—Alzheimer's disease	8.77e-06	0.000406	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOE—Alzheimer's disease	8.77e-06	0.000406	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL2—Alzheimer's disease	8.72e-06	0.000404	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CAV1—Alzheimer's disease	8.69e-06	0.000402	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF1—Alzheimer's disease	8.57e-06	0.000397	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ESR1—Alzheimer's disease	8.37e-06	0.000388	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—F2—Alzheimer's disease	8.27e-06	0.000383	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	8.09e-06	0.000375	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOS3—Alzheimer's disease	7.77e-06	0.00036	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	7.6e-06	0.000352	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GSK3B—Alzheimer's disease	7.59e-06	0.000352	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CREB1—Alzheimer's disease	7.53e-06	0.000349	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CASP3—Alzheimer's disease	7.53e-06	0.000348	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—INS—Alzheimer's disease	7.49e-06	0.000347	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—Alzheimer's disease	7.48e-06	0.000346	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL2—Alzheimer's disease	7.37e-06	0.000341	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF1—Alzheimer's disease	7.25e-06	0.000336	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK8—Alzheimer's disease	6.92e-06	0.00032	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AKT1—Alzheimer's disease	6.9e-06	0.000319	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AKT1—Alzheimer's disease	6.66e-06	0.000308	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CASP3—Alzheimer's disease	6.6e-06	0.000306	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOS3—Alzheimer's disease	6.57e-06	0.000304	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—Alzheimer's disease	6.56e-06	0.000304	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—VEGFA—Alzheimer's disease	6.39e-06	0.000296	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK8—Alzheimer's disease	6.07e-06	0.000281	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AKT1—Alzheimer's disease	6.05e-06	0.00028	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TGFB1—Alzheimer's disease	5.86e-06	0.000271	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	5.63e-06	0.000261	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—VEGFA—Alzheimer's disease	5.6e-06	0.000259	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CASP3—Alzheimer's disease	5.58e-06	0.000258	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—Alzheimer's disease	5.54e-06	0.000257	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TGFB1—Alzheimer's disease	5.14e-06	0.000238	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK8—Alzheimer's disease	5.13e-06	0.000237	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AKT1—Alzheimer's disease	5.11e-06	0.000237	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TP53—Alzheimer's disease	4.83e-06	0.000223	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—VEGFA—Alzheimer's disease	4.73e-06	0.000219	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—Alzheimer's disease	4.42e-06	0.000205	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TGFB1—Alzheimer's disease	4.34e-06	0.000201	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TP53—Alzheimer's disease	4.23e-06	0.000196	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKT1—Alzheimer's disease	4.08e-06	0.000189	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—Alzheimer's disease	3.87e-06	0.000179	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TP53—Alzheimer's disease	3.58e-06	0.000166	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT1—Alzheimer's disease	3.57e-06	0.000165	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—Alzheimer's disease	3.27e-06	0.000152	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT1—Alzheimer's disease	3.02e-06	0.00014	CbGpPWpGaD
